# COMAR Title 10 — Maryland Department of Health

## Subtitle 47 — Alcohol and Drug Abuse Administration

### Chapter 07 — Prescription Drug Monitoring Program

#### Regulation .05-1 Disclosure of Naloxone Medication Data.

*COMAR 10.47.07.05-1*

Disclosure of Naloxone Medication Data for Public Health Surveillance, Research, Analysis, Education, and Public Reporting.

A. The Program shall disclose naloxone medication data for research, analysis, education, and public reporting:

  (1) Upon approval by the Department of a written proposal or abstract explaining the purpose and scope of the research, analysis, education, and public reporting; and

  (2) After redaction of all information that could identify a patient, prescriber, dispenser, or any other individual.

B. The Secretary may waive the requirement of §A(1) of this regulation for requests from units of the Department.

C. The Program may disclose de-identified naloxone medication data for public health surveillance purposes.

D. The Program may not disclose identifiable naloxone medication data to any entity, including but not limited to prescribers or dispensers.